Loading...
Effects of raloxifene on breast cancer cell migration and invasion through the actin cytoskeleton
Raloxifene (RAL) is a selective oestrogen receptor modulator (SERM) approved for the prevention and treatment of osteoporosis and for the prevention of breast cancer in postmenopausal women. However, little is known on the effects of this SERM on breast cancer cell metastasis, which is the main caus...
Na minha lista:
| Udgivet i: | J Cell Mol Med |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Blackwell Publishing Ltd
2008
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6512380/ https://ncbi.nlm.nih.gov/pubmed/18798864 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1582-4934.2008.00505.x |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|